School of Health Administration and Medical Information, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Community Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Int J Health Policy Manag. 2014 May 8;2(4):187-91. doi: 10.15171/ijhpm.2014.44. eCollection 2014 May.
This cross-sectional study was conducted to compare the average costs of breast cancer screening and treatment among women with the age of 25 and over in Shiraz-Iran.
Three majors hospitals affiliated with Shiraz University of Medical Sciences (SUMS) were selected for data collection. Financial documents and interviews with the hospitals' financial officers were used for data collection.
Finding shows that the total cost of screening would be 5,847,544.96 US dollars for age groups of 25-34 and 35 and above, demonstrating the huge expense of screening programs. On the other hand, the average cost of breast cancer treatment for each patient would be 3608.47, 996.89, and 311.47 US dollars for mastectomy, radiotherapy, and chemotherapy, respectively. In addition, the total average cost for treatment of 2217 patients would be 1,466,988.9 US dollars, which is much less than screening programs expenses.
It is concluded that although screening can be effective for improving quality of life and treatment effectiveness, considering the high costs of screening, it is not economical in Iran. Screening methods within suitable intervals, and also considering patients' medical history have been recommended by the present study.
本横断面研究旨在比较伊朗设拉子年龄在 25 岁及以上的女性乳腺癌筛查和治疗的平均成本。
选择隶属于设拉子医科大学(SUMS)的三家主要医院进行数据收集。使用财务文件和对医院财务人员的访谈来收集数据。
研究结果表明,25-34 岁和 35 岁及以上年龄组的筛查总费用将为 5847544.96 美元,显示出筛查计划的巨大费用。另一方面,每位患者乳腺癌治疗的平均费用分别为乳房切除术 3608.47 美元、放疗 996.89 美元和化疗 311.47 美元。此外,2217 名患者的总治疗平均费用为 1466988.9 美元,远低于筛查计划的费用。
尽管筛查可以有效提高生活质量和治疗效果,但考虑到筛查的高成本,在伊朗并不经济。本研究建议采用合适间隔的筛查方法,并考虑患者的病史。